GMIP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.285200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.594800E-01
Normal-vs-Stage2
4.452000E-01
Normal-vs-Stage3
3.939600E-01
Normal-vs-Stage4
4.475600E-01
Stage1-vs-Stage2
1.823030E-01
Stage1-vs-Stage3
6.360800E-01
Stage1-vs-Stage4
1.856760E-01
Stage2-vs-Stage3
4.932400E-01
Stage2-vs-Stage4
9.843600E-01
Stage3-vs-Stage4
5.570200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.262600E-01
Normal-vs-AfricanAmerican
4.142400E-01
Normal-vs-Asian
4.537800E-01
Caucasian-vs-AfricanAmerican
8.478800E-01
Caucasian-vs-Asian
6.280200E-01
AfricanAmerican-vs-Asian
4.347800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.296200E-01
Normal-vs-Female
4.252400E-01
Male-vs-Female
8.590800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.612400E-01
Normal-vs-Age(41-60Yrs)
4.386600E-01
Normal-vs-Age(61-80Yrs)
4.196400E-01
Normal-vs-Age(81-100Yrs)
4.577800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.782800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.354000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.498800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.459800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.517000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.046200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.419600E-01
Normal-vs-Daily Drinker
4.232000E-01
Normal-vs-Weekly Drinker
4.645000E-01
Normal-vs-Occasional Drinker
4.020200E-01
Normal-vs-Social Drinker
4.117600E-01
Non Drinker-vs-Daily Drinker
7.299600E-01
Non Drinker-vs-Weekly Drinker
7.345600E-01
Non Drinker-vs-Occasional Drinker
4.620000E-01
Non Drinker-vs-Social Drinker
5.184000E-01
Daily Drinker-vs-Weekly Drinker
4.946400E-01
Daily Drinker-vs-Occasional Drinker
6.726600E-01
Daily Drinker-vs-Social Drinker
8.107800E-01
Weekly Drinker-vs-Occasional Drinker
2.613200E-01
Weekly Drinker-vs-Social Drinker
3.065000E-01
Occasional Drinker-vs-Social Drinker
8.054600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.572200E-01
Normal-vs-Grade 2
1.355220E-01
Normal-vs-Grade 3
1.669210E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.705160E-01
Grade 1-vs-Grade 3
2.333200E-01
Grade 1-vs-Grade 4
6.572200E-01
Grade 2-vs-Grade 3
7.887800E-01
Grade 2-vs-Grade 4
1.355220E-01
Grade 3-vs-Grade 4
1.669210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.675800E-01
Normal-vs-NonDiabetic
4.124800E-01
Diabetic-vs-NonDiabetic
1.627850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.271800E-01
Normal-vs-NoPancreatitis
4.262200E-01
Pancreatitis-vs-NoPancreatitis
9.949800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.185000E-01
Normal-vs-N1
4.379000E-01
N0-vs-N1
4.790600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.452600E-01
Normal-vs-TP53-NonMutant
3.701800E-01
TP53-Mutant-vs-TP53-NonMutant
4.556000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
